Forbes on TELI: “a more credible scientific origin story”
What sets TELI apart, according to Forbes.
TELI by Elysium <[email protected]>
Share
Elysium Health promotes its new longevity institute, TELI, a physician-led program emphasizing scientific rigor and personalized protocols. Forbes features TELI, highlighting its credible scientific origin story and approach to longevity care. Elysium Health is positioning TELI as a clinical operating system for the booming longevity market.
What the raw message shows
From the headers
- Sent with
-
Customer.io See it in the headers
Across Elysium Health's email
- Sends
- About 2 a week
- DMARC
-
Enforced, quarantine
Mail failing authentication goes to spam.
The copy
282 words · about 1 min to read
The Elysium Longevity Institute | A new standard for longevity medicine is making Forbes headlines: lifestyle | Inside Elysium Health’s new longevity institute | “A decade after helping take NAD+ mainstream, the company is opening a physician-led program called TELI that treats rigor as the product, and emphasizes inventory isn’t what the category is missing.” By Tanya Akim | Published Sep 25, 2026, 6:22pm EDT
Forbes takes an inside look at The Elysium Longevity Institute (TELI) and the decade of science behind it. Contributor Tanya Akim traces Elysium's story back to Dr. Leonard Guarente’s lab at MIT, which “helped define modern sirtuin and NAD+ biology.” From those scientific roots to the launch of TELI, the article explores Elysium's evolution—and the commitment to scientific rigor guiding its next chapter. | Elysium has a more credible scientific origin story than most.
TELI brings that scientific foundation to a new model of longevity care. As Forbes explains, TELI isn't a traditional brick-and-mortar clinic, but a nationwide telehealth program that pairs licensed providers with personalized protocols—and “keeps the relationship open so the plan can change as a patient’s health does.” It's an approach built around ongoing clinical oversight rather than one-time transactions. As Akim puts it, “protocols are meant to be adjusted over time, not locked at checkout.”
Looking ahead, Forbes describes TELI as Elysium’s move beyond being “the serious NAD+ company” toward becoming the company that determines “which longevity tools deserve a physician’s name on the order.” It's an ambitious next chapter—one that extends Elysium's commitment to scientific rigor into the rapidly evolving field of longevity medicine. | Elysium is arguing that the booming longevity market needs a clinical operating system.
Get started with TELI
The words as text: what a screen reader can follow, and all there is when images don't load.
What the headers say
Read from the message's own headers, as it arrived.
- Came from
-
a14.a355d2fe.use4.send.mailgun.net
· 198.244.52.14
Customer.io's sending servers
- SPF
- Pass for cio156609.elysiumhealthrx.com
- DKIM
-
- Pass signed by cio156609.elysiumhealthrx.com
- DMARC
-
Pass for elysiumhealthrx.com
Policy: none, so failures would still be delivered
- Unsubscribe
-
One-click
Meets the Gmail and Yahoo rule for bulk senders.
- Complaints
- No feedback-loop header
Show all 22 headers Hide the headers
As received, minus the delivery side: the archive's own addresses show as [recipient], its mail servers as [receiver], signatures are left out and unsubscribe links trimmed to their host.
Route
- Received
- from a14.a355d2fe.use4.send.mailgun.net (198.244.52.14) by [receiver] (cloudflare) id qHsErz0SPRLn for <[recipient]>; Wed, 04 Nov 2026 17:15:12 +0000
- Received
- by b3930acc18287533e14c33075f944ab25481eba66267ebb8b754e699ee32bef6 with HTTP id 6aeb681aed5ed4b5073b18e8; Wed, 04 Nov 2026 17:15:06 GMT
Authentication
- Received-SPF Authentication result
- pass ([receiver]: domain of [email protected] designates 198.244.52.14 as permitted sender) receiver=[receiver]; client-ip=198.244.52.14; envelope-from="[email protected]"; helo=a14.a355d2fe.use4.send.mailgun.net;
- Authentication-Results Authentication result
- [receiver]; dkim=pass header.d=cio156609.elysiumhealthrx.com header.s=cio header.b=GaScsJml; dmarc=pass header.from=elysiumhealthrx.com policy.dmarc=none; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=a14.a355d2fe.use4.send.mailgun.net; spf=pass ([receiver]: domain of [email protected] designates 198.244.52.14 as permitted sender) [email protected]; arc=none smtp.remote-ip=198.244.52.14
Platform
- X-Mailgun-Sid
- WyIxODg5MCIsImVseXNpdW1AaW5ib3hhcmNoaXZlLm9yZyIsImFlOWU2ZGMiXQ==
- X-Mailgun-Sending-Ip
- 198.244.52.14
- X-Mailgun-Dkim
- true
- X-Mailgun-Native-Send
- true
- X-Mailgun-Track-Clicks
- false
- X-Mailgun-Track-Opens
- false
- X-Mailer Identifies Customer.io
- Customer.io (dgSi0w0DAMLSBsHSBgGhp46h7WvN4kHV39fwBo8=; +https://whatis.customeriomail.com)
- X-Report-Abuse-To Identifies Customer.io
- [email protected]
- X-Mailgun-Variables
- {"email_id": "dgSi0w0DAMLSBsHSBgGhp46h7WvN4kHV39fwBo8="}
Unsubscribe and feedback
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
- List-Unsubscribe
- <mailto:…@unsubscribe2.customer.io>, <https://e.elysiumhealthrx.com/…>
Message
- Date
- Wed, 04 Nov 2026 17:15:06 +0000
- Mime-Version
- 1.0
- Content-Type
- multipart/alternative; boundary="36d6ae500c146cb0c5f9ab4381c9a56987504759d130d6d19f27811b4b7b"
- Subject
- Forbes on TELI: “a more credible scientific origin story”
- From
- TELI by Elysium <[email protected]>
- Reply-To
- TELI by Elysium <[email protected]>
- Message-Id
- <[email protected]>
More from Elysium Health
All 37 emailsSimilar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.